Transcribed Image Text from this Question
Distribution of a COVID-19 Vaccine Once a vaccine for COVID-19 has been developed and approved, it is then ready for distribution. How do you think it should be shared fairly around the world? How do you think it should be shared fairly within the United States? Governments must start looking now for an ethical and equitable domestic and global process, and it won’t be easy. i The Observer Once we have a vaccine, how will it be shared fairly around the world? Governments must start looking now for an ethical and equitable global process, and it won’t be easy, experts warn Coronavirus – latest updates See all our coronavirus coverage In December 2006, the Indonesian authorities refused to hand over samples of the bird flu virus without guarantees that it would benefit from any vaccine produced from them. Amid the swine flu outbreak in 2009, the Australian government ordered a vaccine manufacturer to meet its demand before fulfilling orders overseas. That November, after several rich nations had secured vaccines, officials from the World Health Organization aired concerns that disaster could lie ahead. Advertisement WIL “Things would be much worse if the pandemic had been more severe, and it 3:01 Advertisement X fai Action Alerts PLUS The Street M: SIGN UP NOW Dxd “Things would be much worse if the pandemic had been more severe, and it would be more difficult to create some fairness in the distribution of vaccine,” said Marie-Paule Kieny, the then head of the WHO’s initiative for vaccine research. “Governments might be less inclined to share the vaccine that they have.” With vaccines seen as one of the few real routes out of the coronavirus crisis, fears of “vaccine nationalism” are already increasing. Each step of creating, testing and mass-producing a vaccine is an epic challenge – but the political and ethical decisions around its subsequent distribution pose another. Governments, including in the UK, are being questioned about how they will get to the front of the queue. How will any eventual vaccine be shared out? Who decides? Will supplies go to the highest bidder? Are rich nations buying up potential vaccines already? And what will stop governments from simply seizing vaccines made in their country? According to experts and industry, it will talentinant naninnto the la Advertisement х frc Action Alerts PLUS The Street [Р Х av 14 DAYS FREE gs 111iuunny 111 In vn, uit vn qucutivnu about how they will get to the front of the queue. How will any eventual vaccine be shared out? Who decides? Will supplies go to the highest bidder? Are rich nations buying up potential vaccines already? And what will stop governments from simply seizing vaccines made in their country? According to experts and industry, it will take at least a year to vaccinate the world from the moment vaccines become available. That’s a 12-month queue, if things go well – after a vaccine is found. “The reality is that there is no process established for this,” says Steven Jones, a Canadian member of a team that created a successful Ebola vaccine. писиипп% псис о, иіс осп5 часососа about how they will get to the front of the queue. How will any eventual vaccine be shared out? Who decides? Will supplies go to the highest bidder? Are rich nations buying up potential vaccines already? And what will stop governments from simply seizing vaccines made in their country? According to experts and industry, it will take at least a year to vaccinate the world from the moment vaccines become available. That’s a 12-month queue, if things go well – after a vaccine is found. “The reality is that there is no process established for this,” says Steven Jones, a Canadian member of a team that created a successful Ebola vaccine. “Things would be much worse if the pandemic had been more severe, and it would be more difficult to create some fairness in the distribution of vaccine,” said Marie-Paule Kieny, the then head of the WHO’s initiative for vaccine research. “Governments might be less inclined to share the vaccine that they have.” With vaccines seen as one of the few real routes out of the coronavirus crisis, fears of “vaccine nationalism” are already increasing. Each step of creating, testing and mass-producing a vaccine is an epic challenge – but the political and ethical decisions around its subsequent distribution pose another. Governments, including in the UK, are being questioned about how they will get to the front of the queue. How will any eventual vaccine be shared out? Who decides? Will supplies go to the highest bidder? Are rich nations buying up potential vaccines already? And what will stop governments from simply seizing vaccines made in their country? According to experts and industry, it will talent Innat noninnto the la Advertisement х frc Action Alerts PLUS The Street [Р Х gs av 14 DAYS FREE Prepare a written report of the case using the following format: 1. Background statement. What is going on in this case scenario? Explain the immunization distribution issue in your own words. 2. Major problem(s). Identify the major problem (s) of immunization distribution. Analyze the causes and effect. 3. Strengths and weaknesses. What public health strengths are part of this situation? What weaknesses need to be addressed? 4. Resolution. What strategies would you recommend to help solve the issue? State what should be done–why, how, and by whom. 5. Evaluation. How will you evaluate the success of your suggested resolution(s)? i The Observer Once we have a vaccine, how will it be shared fairly around the world? Governments must start looking now for an ethical and equitable global process, and it won’t be easy, experts warn Coronavirus – latest updates See all our coronavirus coverage In December 2006, the Indonesian authorities refused to hand over samples of the bird flu virus without guarantees that it would benefit from any vaccine produced from them. Amid the swine flu outbreak in 2009, the Australian government ordered a vaccine manufacturer to meet its demand before fulfilling orders overseas. That November, after several rich nations had secured vaccines, officials from the World Health Organization aired concerns that disaster could lie ahead. Advertisement wc 12 “Things would be much worse if the pandemic had been more severe, and it Advertisement fai Action Alerts PLUS TheStreet M: SIGN UP NOW Dxd “Things would be much worse if the pandemic had been more severe, and it would be more difficult to create some fairness in the distribution of vaccine,” said Marie-Paule Kieny, the then head of the WHO’s initiative for vaccine research. “Governments might be less inclined to share the vaccine that they have.” With vaccines seen as one of the few real routes out of the coronavirus crisis, fears of “vaccine nationalism” are already increasing. Each step of creating, testing and mass-producing a vaccine is an epic challenge – but the political and ethical decisions around its subsequent distribution pose another. Governments, including in the UK, are being questioned about how they will get to the front of the queue. How will any eventual vaccine be shared out? Who decides? Will supplies go to the highest bidder? Are rich nations buying up potential vaccines already? And what will stop governments from simply seizing vaccines made in their country? According to experts and industry, it will tal. – Inant nanimata tha….la Advertisement fre Action Alerts PLUS The Street х av 14 DAYS FREE gs about how they will get to the front of the queue. How will any eventual vaccine be shared out? Who decides? Will supplies go to the highest bidder? Are rich nations buying up potential vaccines already? And what will stop governments from simply seizing vaccines made in their country? According to experts and industry, it will take at least a year to vaccinate the world from the moment vaccines become available. That’s a 12-month queue, if things go well – after a vaccine is found. “The reality is that there is no process established for this,” says Steven Jones, a Canadian member of a team that created a successful Ebola vaccine. Advertisement 1. Background statement. What is going on in this case scenario? Explain the immunization distribution issue in your own words. 2. Major problem(s). Identify the major problem (s) of immunization distribution. Analyze the causes and effect. 3. Strengths and weaknesses. What public health strengths are part of this situation? What weaknesses need to be addressed? 4. Resolution. What strategies would you recommend to help solve the issue? State what should be done–why, how, and by whom. 5. Evaluation. How will you evaluate the success of your suggested resolution(s)?
(Visited 2 times, 1 visits today)
